home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
governance
stock chart
Contact
Menu
home
ABOUT
company profile
Strategy
Management Team & Board Of Directors
Products
PRF-110
Product Pipeline
Clinical Trials
Market
Investors
press releases
sec filling
presentations
events
governance
stock chart
Contact
Investor relations
Investors lobby
company profile
press releases
presentations
events
governance
stock chart
Sec Filings
Contact
Menu
Investors lobby
company profile
press releases
presentations
events
governance
stock chart
Sec Filings
Contact
press releases
09/11/2024
PainReform Ltd. Confirms Sutures Compatibilityin Human Clinical Trials for PRF-110
read more
09/10/2024
PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds
read more
08/21/2024
PainReform Bunionectomy Study Observations Confirm Optimal Delivery Method for PRF-110 in Bunionectomy Procedures
read more
08/20/2024
PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study
read more
08/15/2024
PainReform Provides Business Update for the Second Quarter of 2024
read more
08/12/2024
PainReform Announces Development and Successful Manufacturing of New Formulations Providing Anti-Inflammatory and Extended Analgesic Effects
read more
